Cargando…

A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient

Aim: Dyslipidemia is the most common lipid metabolism disorder in humans, and its etiology remains elusive. Hypertriglyceridemia (HTG) is a type of dyslipidemia that contributes to atherosclerosis and coronary heart disease. Previous studies have demonstrated that mutations in lipoprotein lipase (LP...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yihui, Xu, Jiang, Tao, Wanyun, Yu, Rong, Zhang, Xinjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365152/
https://www.ncbi.nlm.nih.gov/pubmed/29910226
http://dx.doi.org/10.5551/jat.44537
_version_ 1783393371036844032
author Liu, Yihui
Xu, Jiang
Tao, Wanyun
Yu, Rong
Zhang, Xinjiang
author_facet Liu, Yihui
Xu, Jiang
Tao, Wanyun
Yu, Rong
Zhang, Xinjiang
author_sort Liu, Yihui
collection PubMed
description Aim: Dyslipidemia is the most common lipid metabolism disorder in humans, and its etiology remains elusive. Hypertriglyceridemia (HTG) is a type of dyslipidemia that contributes to atherosclerosis and coronary heart disease. Previous studies have demonstrated that mutations in lipoprotein lipase (LPL), apolipoprotein CII (APOC2), apolipoprotein AV (APOA5), glycosylphosphatidylinositol anchored high-density lipoprotein-binding protein 1 (GPIHBP1), lipase maturation factor 1 (LMF1), and glycerol-3 phosphate dehydrogenase 1 (GPD1) are responsible for HTG by using genomic microarrays and next-generation sequencing. The aim of this study was to identify genetic lesions in patients with HTG. Method: Our study included a family of seven members from Jiangsu province across three generations. The proband was diagnosed with severe HTG, with a plasma triglyceride level of 38.70 mmol/L. Polymerase chain reaction (PCR) and Sanger sequencing were performed to explore the possible causative gene mutations for this patient. Furthermore, we measured the post-heparin LPL and hepatic lipase (HL) activities using an antiserum inhibition method. Results: A compound heterozygous mutation in the LMF1 gene (c.257C > T/p.P86L and c.1184C > T/p. T395I) was identified and co-segregated with the affected patient in this family. Both mutations were predicted to be deleterious by three bioinformatics programs (Polymorphism Phenotyping-2, Sorting Intolerant From Tolerant, and MutationTaster). The levels of the plasma post-heparin LPL and HL activities in the proband (57 and 177 mU/mL) were reduced to 24% and 75%, respectively, compared with those assayed in the control subject with normal plasma triglycerides. Conclusion: A compound heterozygous mutation of LMF1 was identified in the presenting patient with severe HTG. These findings expand on the spectrum of LMF1 mutations and contribute to the genetic diagnosis and counseling of families with HTG.
format Online
Article
Text
id pubmed-6365152
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Japan Atherosclerosis Society
record_format MEDLINE/PubMed
spelling pubmed-63651522019-02-08 A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient Liu, Yihui Xu, Jiang Tao, Wanyun Yu, Rong Zhang, Xinjiang J Atheroscler Thromb Original Article Aim: Dyslipidemia is the most common lipid metabolism disorder in humans, and its etiology remains elusive. Hypertriglyceridemia (HTG) is a type of dyslipidemia that contributes to atherosclerosis and coronary heart disease. Previous studies have demonstrated that mutations in lipoprotein lipase (LPL), apolipoprotein CII (APOC2), apolipoprotein AV (APOA5), glycosylphosphatidylinositol anchored high-density lipoprotein-binding protein 1 (GPIHBP1), lipase maturation factor 1 (LMF1), and glycerol-3 phosphate dehydrogenase 1 (GPD1) are responsible for HTG by using genomic microarrays and next-generation sequencing. The aim of this study was to identify genetic lesions in patients with HTG. Method: Our study included a family of seven members from Jiangsu province across three generations. The proband was diagnosed with severe HTG, with a plasma triglyceride level of 38.70 mmol/L. Polymerase chain reaction (PCR) and Sanger sequencing were performed to explore the possible causative gene mutations for this patient. Furthermore, we measured the post-heparin LPL and hepatic lipase (HL) activities using an antiserum inhibition method. Results: A compound heterozygous mutation in the LMF1 gene (c.257C > T/p.P86L and c.1184C > T/p. T395I) was identified and co-segregated with the affected patient in this family. Both mutations were predicted to be deleterious by three bioinformatics programs (Polymorphism Phenotyping-2, Sorting Intolerant From Tolerant, and MutationTaster). The levels of the plasma post-heparin LPL and HL activities in the proband (57 and 177 mU/mL) were reduced to 24% and 75%, respectively, compared with those assayed in the control subject with normal plasma triglycerides. Conclusion: A compound heterozygous mutation of LMF1 was identified in the presenting patient with severe HTG. These findings expand on the spectrum of LMF1 mutations and contribute to the genetic diagnosis and counseling of families with HTG. Japan Atherosclerosis Society 2019-02-01 /pmc/articles/PMC6365152/ /pubmed/29910226 http://dx.doi.org/10.5551/jat.44537 Text en 2019 Japan Atherosclerosis Society This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Original Article
Liu, Yihui
Xu, Jiang
Tao, Wanyun
Yu, Rong
Zhang, Xinjiang
A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient
title A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient
title_full A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient
title_fullStr A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient
title_full_unstemmed A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient
title_short A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient
title_sort compound heterozygous mutation of lipase maturation factor 1 is responsible for hypertriglyceridemia of a patient
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365152/
https://www.ncbi.nlm.nih.gov/pubmed/29910226
http://dx.doi.org/10.5551/jat.44537
work_keys_str_mv AT liuyihui acompoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient
AT xujiang acompoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient
AT taowanyun acompoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient
AT yurong acompoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient
AT zhangxinjiang acompoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient
AT liuyihui compoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient
AT xujiang compoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient
AT taowanyun compoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient
AT yurong compoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient
AT zhangxinjiang compoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient